Introduction
Asthma is mainly characterized by chronic bronchial inflammation and hyperresponsiveness [1, 2] . The disease phenotype in humans encompasses generally repeated episodes of non permanent airway obstruction along with wheezing, breathlessness and cough. Mouse models of asthma mimic most of these human asthma features and provide valuable tools for deciphering disease mechanisms [3] . Such mouse models have proven valuable for elucidating the implication of specific gene products, such as matrix proteinases. Therefore, several research groups have studied the asthmatic phenotype by using knock-out animals and reported that MMP-9 depleted mice display a lower cell infiltration and bronchial responsiveness upon allergen exposure [4] . In sharp contrast, MMP-8 deficiency promotes a neutrophilic inflammation in the airways [5] and MMP-2 deficiency induces inflammatory cell accumulation in lung parenchyma responsible for asphyxia in some animals [6] .
ADAMs (A Disintegrin And Metalloproteinases) belong to the metzincin superfamily of proteinases. The typical structure of ADAM proteinases consists of metalloproteinase, disintegrin, and cytoplasmic domains which endow the protein with catalytic activity, adhesion properties, and potentially signaling functions [7] [8] [9] [10] .
Light was shed on the potential role of ADAM proteinases in asthma by a genetic association study demonstrating a link between increased risk of asthma development and polymorphisms in the ADAM-33 gene [11] . It was also reported that ADAM-33 gene expression correlates with asthma severity [12] . ADAM-8 is another member of the ADAM family displaying some structural similarities with ADAM-33.
ADAM-8 has been first cloned from mouse macrophages [13] and is expressed at baseline or after stimulation by a wide range of cell types including neurons, 4 osteoclasts, bronchial epithelial cells and cells of the immune system (eosinophils, polymorphonuclear leukocytes (PMN), monocytes, macrophages, dendritic cells and B lymphocytes) [13] [14] [15] [16] [17] . ADAM-8 is implicated in various complex biological processes such as neurodegenerative inflammation and osteoclastogenesis [18, 19] .
Moreover, two distinct studies based on a wide genome microarray have shown that ADAM-8 mRNA expression appears to be increased in asthma [20, 21] . More recently, transgenic mice overexpressing a soluble form of ADAM-8 (sADAM-8) in liver tissue showed less cellular infiltration in an allergen-induced model of lung inflammation, suggesting that sADAM-8 might play a role as inflammation inhibitor [22] . Known biological functions of ADAM-8 are to date restricted to cell fusion and adhesion [23] . ADAM-8 also appears to be a sheddase and cleaves CD23, neural cell adhesion molecule close homologue of L1 (CHL1), beta-amyloid precursor protein (APP), L-selectin, vascular cell adhesion molecule-1 (VCAM-1), and myelin basic protein (MBP) while there is also evidence for a possible cleavage of pro-tumor necrosis factor (TNF) α and CD16 [24, 25] rendering plausible a role as inflammation modulator for this proteinase [25] [26] [27] . However, the question of whether ADAM-8 is involved in the development of asthma phenotype remains unanswered.
In this study, we demonstrate through both genetic and antibody-based approaches that ADAM-8 is a key mediator for the development of asthma-linked inflammation.
We describe that ADAM-8 depletion (transgenic mice deficient for ADAM-8) and injected antibodies raised against ADAM-8 impair the development of airway inflammation after allergen exposure. We also explored the mechanisms implicating ADAM-8 and report that ADAM-8 depletion modifies dendritic cell recruitment and production of key cytokines contributing to the network of interactions leading to eosinophilic inflammation.
Results

ADAM-8 expression and production in lungs of mice acutely exposed to allergens
In order to investigate ADAM-8 expression in an experimental model of asthma, male Balb/c mice were sensitized and subsequently exposed to ovalbumin (OVA) for 5 days. As expected, mice exposed to OVA showed higher BALF eosinophil percentages and peribronchial inflammation as compared to mice exposed to PBS (eosinophil percentage: 1.700±1.361 in sham-exposed mice versus 56.187±6.255 in allergen-exposed mice, p<0.0001; inflammation score: 0.325±0.067 in sham-exposed mice versus 1.161±0.084 in allergen-exposed mice, p<0.0001). ADAM-8 was significantly upregulated at mRNA level in lung parenchyma of mice acutely exposed to allergens as compared to controls (figure 1A and C). Moreover, ADAM-8 protein production was also significantly increased in OVA-exposed mice as assessed by Western blotting and immunohistochemistry (figure 1B, D and E). Interestingly, the immunohistochemical analysis revealed that ADAM-8 stained cells mostly correspond to inflammatory cells such as eosinophils and macrophages located in the peribronchial area ( figure 1E ).
ADAM-8 expression and production in chronic allergen-induced remodeling
In order to further investigate ADAM-8 expression and production in a chronic remodeling model of asthma, male Balb/c mice were sensitized and subsequently exposed to OVA for 5 days per week (odd weeks) from days 22 to 96 (eosinophil percentage: 4.033±0.704 in sham-exposed mice versus 24.600±1.613 in allergenexposed mice, p<0.0001; inflammation score: 0.593±0.096 in sham-exposed mice versus 1.129±0.061 in allergen-exposed mice, p<0.05; glandular hyperplasia expressed in positive cells percentage: 0.062±0.062 in sham-exposed mice versus 6 33.640±4.363 in allergen-exposed mice, p<0.0001; basement membrane collagen: 0.654±0.046 in sham-exposed mice versus 1.444±0.070 in allergen-exposed mice, p<0.0001). In this long-term model, mRNA levels of ADAM-8 were only poorly detectable ( figure 1A ) and the ADAM-8 protein production was very weak (figure 1B).
Moreover, no significant difference between mice exposed to allergen or not was observed by RT-PCR and Western blotting.
ADAM-8 blockade by antibody treatment
In order to assess the implication of ADAM-8 in asthma-related acute inflammation, Balb/c mice were treated with an anti-ADAM-8 antibody for 3 days while a control isotype was injected to control Balb/c mice. Two hours after antibody injection, mice Moreover, decrease of eosinophilia BALF was assessed in both Th 2 -prone mice (Balb/c) and non Th 2 -prone (C57Bl/6) and found to be similar ( figure 2D ).
Acute allergen-induced inflammation in ADAM-8 -/-animals
We also applied the allergen-induced acute inflammation model to ADAM-8 deficient figure 3A-B) . In mice exposed to OVA, CCL22 levels were positively correlated with eosinophil counts in the lung tissues (r=0.7598 and p=0.0004, 
ADAM-8 expression in lung dendritic cells
In order to verify the potential implication of ADAM-8 in immunological processes leading to asthma-related acute inflammation, we performed a RT-PCR on mRNA from dendritic cells extracted from lungs of mice acutely exposed to allergens. Levels of mRNA coding for ADAM-8 were higher in allergen-exposed mice as compared to control mice (figure 4E-F), suggesting that ADAM-8 might be a key regulator of dendritic cells behavior. Additionally, ADAM-8 expression was assessed by RT-PCR in other major cellular sources in the lung such as epithelial cells, eosinophils, alveolar macrophages and interstitial macrophages ( Figure 4G ).
Discussion
We designed the present study to investigate the potential role of the metalloproteinase ADAM-8 in allergen-induced airway diseases. Through genetic and pharmacological approaches in two different strains of mice (Balb/c, Th 2 -prone and C57Bl/6, Th 1 -prone), we report that ADAM-8 significantly contributes to the establishment of acute allergen-induced inflammation in asthma. This novel concept is based on the findings that anti-ADAM-8 antibody-treated mice and ADAM-8-deficient mice displayed significantly decreased levels of allergen-induced acute inflammation in BAL and in peribronchial areas. We also report for the first time that ADAM-8 is overexpressed in lung dendritic cells after allergen exposure. Moreover, we found increased levels of CCL11 and CCL22 after allergen exposure in ADAM-8 +/+ mice while these two cytokines failed to increase in ADAM-8 -/-animals displaying therefore levels similar to sham-exposed mice for those two cytokines. We also reported a decrease of CCL11 and CCL22 production in anti-ADAM-8-treated mice.
To explore the mechanism leading to a decrease of CCL22, we measured the numbers of dendritic cells and alveolar macrophages in the lung parenchyma and described a significant decrease of those two cell types in lungs of ADAM-8 -/-animals. Moreover, CCL22 levels were highly correlated to eosinophilic inflammation in allergen-exposed animals. Finally, we also demonstrate that the expression and production of ADAM-8 proteinase were not chronically modulated in chronic asthma and therefore could not play significant roles in remodeling processes linked to asthma.
These novel findings are in accordance with emerging data on the implication of ADAM-8 in the pathogenesis of pulmonary diseases [28] and suggest that ADAM-8 might be a key regulator of dendritic cells and alveolar macrophages homeostasis. [21] . A genomic study recently reported a link between ADAM-8 single nucleotide polymorphisms and asthma in humans [30] . In addition, two separate genome-wide searches performed on mice subjected to allergen exposure discriminated ADAM-8 as a valid marker of allergen-induced inflammation [20, 21] .
Interestingly, one of these studies compared different durations of exposure to allergens and reported that ADAM-8 was overexpressed only in acute models while ADAM-8 overexpression was not reported after chronic allergen exposures [20] . In line with this recent study of Di Valentin et al who performed microarray studies, we emphasized the role of ADAM-8 in acute inflammation and not in chronic remodeling associated to asthma. Moreover, this is in keeping with the findings of Matsuno et al who showed that ADAM-8 levels are increased in patients suffering from acute eosinophilic pneumonia but not chronic idiopathic eosinophilic pneumonia [31] . In our study, we report that there is less eosinophilia in the BAL in ADAM-8 KO mice. As a consequence of these huge variations in eosinophil counts, we also found that total cell counts were significantly decreased in ADAM-8 KO animals.
Since there is no difference in features of chronic remodeling established between ADAM-8 deficient mice and wild-type mice exposed to allergens, we hypothesize that ADAM-8 is only implicated in acute airway inflammation. ADAM-8 cleaves various key molecules in inflammatory processes including CD23, pro-TNF-α and L-selectin [25, 26] . From this substrate specificity, it can be deduced that ADAM-8 might be an effector in immunological processes [22, 29] . However, ADAM-8 -/-mice did not display any developmental abnormalities and their immune system was previously reported as not impaired by ADAM-8 gene deletion [32] . We verified that unchallenged ADAM-8 -/-mice bear normal eosinophil percentages in their blood by studying blood smears (data not shown).
Our experiments using ADAM-8 -/-animals and anti-ADAM-8 treatment demonstrate that ADAM-8 is per se responsible for a significantly increased allergen-induced acute inflammation both in lung tissue and BAL. In order to rule out the potential role of mice genetic background in our results, we compared the Th 2 -prone strain Balb/c with Th 1 -prone C57Bl/6 in the antibody-blocking experiment and we report similar decreases of lung inflammation. This validates our study on ADAM-8 genetically depleted mice performed on a Th 1 -prone background (129/Ola; C57Bl/6 mixed genetic background as most of KO mice). These experiments allow us to demonstrate that the effects of ADAM-8 depletion reported in the present study are not restricted to a specific strain and probably correspond to a conserved mechanism. In a first approach, our results could seem in apparent discrepancy with those generated by Matsuno et al [22] using mice overexpressing soluble ADAM-8 in the liver. Indeed, these authors reported that sADAM-8 overexpressing mice were protected from the development of histological inflammation when subjected to asthma induction (noteworthy, these authors did not find any variation of BAL inflammation) [22] . However, transgenic mice used by these previous authors express normal levels of membrane-bound ADAM-8 in their tissues and have an excess of sADAM-8 in their plasma, released from the liver, rendering the final picture far more complex than targeted gene deletion. Moreover, one cannot exclude the possibility that, in this setting, sADAM-8 might display some specific biological activities different from membrane-bound ADAM-8.
Mechanisms that could explain such a decrease in eosinophils as we observed in ADAM-8 -/-and anti-ADAM-8-treated mice could be linked to a decreased production of CCL11 and CCL22, two chemo-attractants for eosinophils [33, 34] . CCL22, referred to as macrophage-derived chemokine (MDC), also takes part to Th2 inflammation. Interestingly, immunostainings performed in humans and mice suggested that cells producing ADAM-8 are mostly eosinophils [21, 29] . As CCL11
(eotaxin-1) is mainly secreted by eosinophils, a significant decrease of those cells, as reported in the present study might account per se for lower levels of CCL11 found after ADAM-8 inhibition. By contrast, CCL22 is mostly produced by macrophages and dendritic cells [35, 36] and appears to play a central role in allergen-induced inflammation since it is produced by Th 2 -induced dendritic cells [37] . As demonstrated in this study, number of macrophages and dendritic cells present in lung tissue in allergen-exposed ADAM-8 -/-mice is lower than ADAM-8 +/+ mice.
Very recently, other authors have reported that ADAM-8 is detectable in bronchial epithelium and smooth muscle cells [38] . In contrast with these observations, our own Our results are in accordance with a very recent paper published on-line during the revision period of this manuscript and reporting that genetic depletion of ADAM-8 is protective against main features of asthma [39] .
We conclude that ADAM-8 is not only a marker of allergen-induced acute inflammation but probably also an effector since its depletion impairs the development of eosinophilic inflammation through decreasing lung dendritic cells and alveolar macrophages and modulating CCL11 and CCL22 production.
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Material and Methods
Experimental asthma protocol
Six to 8 weeks old Balb/c male mice were provided by the animal house of the University of Liège (Belgium). ADAM-8 deficient mice and corresponding wild-type mice were kindly provided by Dr. Andrew Docherty (UCB-Celltech, Slough, UK).
ADAM-8 knock-out (KO) mice display a 129/Ola; C57/BL/6 mixed genetic background and only brethren were used. We used only male ADAM-8 KO mice or controls in our experimental procedures. In order to perform a genotyping to ensure that animals were homozygous KO or homozygous WT before entering our experimental protocols, DNA was obtained from mice tails by "Machery-Nagel
Nucleospin®Tissue" kit. Primer pair used to distinguish KO and WT is:
CACTGTTGGACTGGCTAAGGTG and GACATCGGTAACATTGGTCAG. Protocols minutes. In the control group, mice were exposed to PBS aerosols. Mice were sacrificed 24 hours after the last allergen exposure. For the remodeling model, mice were sensitized by intraperitoneal injections on days 0 and 11, and groups of mice were exposed to OVA or PBS aerosols 5 days per week (odd weeks) from days 22 to 96. As described in the "acute inflammation model", mice were sacrificed 24h after the last allergen exposure. We used OVA from one single batch that has been characterized regarding endotoxin content. We have performed endotoxin measurement (Lonza, Braine-l'Alleud, Belgium). Mean measured endotoxin levels in the current batch of OVA are 0.236 ng of endotoxin/gr of OVA. We also ensured that PBS used in our experiment was endotoxin-free (manufacturer specifications indicate no detectable levels of endotoxin).
ADAM-8 blockade by antibody treatment
On days 0 and 7, male Balb/c and C57Bl/6 mice were sensitized by intraperitoneal 
Bronchoalveolar lavage fluid (BALF)
After sacrifice, a canula was inserted in the trachea of the mouse and BALF was performed manually by instillation of 4x1ml of PBS-EDTA 0.05mM (Calbiochem, Darmstadt, Germany). BAL was subjected to centrifugation for 10 minutes at 4°C and at 282 x g. Supernatants were stored at -80°C for future assessments while cell pellets were resuspended in 1ml PBS-EDTA 0.05mM in order to proceed with total and differential cell counts. Total cell number was measured by using a Z2 coulterΧ ® particle count and size analyzer (Beckman Coulter, Analis, Namur, Belgium) and differential cell count was assessed by a skilled observer blinded to experimental details, based on morphological criteria. For this purpose, cells were centrifuged (cytospin) on a slide and stained with Diff Quick ® (Dade, Brussels, Belgium).
Lung tissue processing
After recovering the BAL, thorax was opened and left lung was clamped. The right lung was cut and snap frozen in liquid nitrogen for RNA and protein extraction whereas the left lung was insufflated at constant pressure with 4% paraformaldehyde and then embedded in paraffin for histological analysis.
Histological analysis
Histological analyses were performed on 5 µm lung tissue sections. Sections were stained with hematoxylin and eosin and a peribronchial inflammation score was applied to each slide as previously reported [5] . Briefly, score 0 was assigned for USA) diluted at 1:500. After rinsing, rabbit anti-goat biotin coupled secondary antibody was applied on the slides followed by incubation with streptavidin/HRP (horse radish peroxydase) complex (Dako, Glostrup, Denmark). Peroxidase activity was revealed using the 3-3' diaminobenzidine hydrochlorid kit (DAB, Dako, Glostrup, Denmark).
For dendritic cells and alveolar macrophages detection, slides were deparaffinized and, after treatment with trypsin 0.1% (Sigma-Aldrich, Schnelldorf, Germany), endogenous peroxidases were blocked with H 2 O 2 3% (Merck, Darmstadt, Germany).
Slides were then incubated with hamster anti-CD11c (Abcam, Cambridge, UK) diluted 1:50 or rat anti-F4/80 antibody (Serotec, Düsseldorf, Germany) diluted at 1:100. After rinsing, goat anti-hamster or rabbit anti-rat biotin coupled secondary antibody was applied on the slides followed by incubation with streptavidin/HRP (horse radish peroxydase) complex (Dako, Glostrup, Denmark). Peroxidase activity was revealed using the 3-3' diaminobenzidine hydrochlorid kit (DAB, Dako, Glostrup, Denmark).
Lung RNA/protein extraction
Tissues were disrupted and completely homogenized forming a powder by a combination of turbulence and mechanical shearing and total RNA was extracted using RNeasy Mini kit following manufacturer's instructions (Qiagen, Gmbh D, Hilden, Germany). Total protein extracts were prepared by incubating crushed lung tissues in a 2M urea solution. Tissue lysates were centrifuged for 15 minutes at 16,100 x g.
Cell isolation
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To obtain single-lung-cell suspensions, lungs were perfused with 5 ml PBS through the right ventricle, cut into small pieces, and digested for 1 hour at 37°C in 1 mg/ml collagenase A (Roche, Mannheim, Germany) and 0.05 mg/ml DNaseI (Roche, Mannheim, Germany) in HBSS. Lung DCs were isolated using criteria of CD11c + /F4/80 -cells, as previously described by Bedoret et al [40] . Cells were sorted by flow cytometry (FACSAria). The purity of isolated dendritic cells is about 91%.
Alveolar macrophages (AM) and interstitial macrophages (IM) were isolated using following criteria: CD11c + /F4/80 + cells, and CD11c -/F4/80 + cells, respectively.
Eosinophils were isolated using criteria GR1 + /CCR3 + while epithelial cells were isolated using laser capture microdissection (LCM) system (Leica). seconds, 64°C for 20 seconds, and 72° for 10 seconds for 28 cycles, followed by 2 minutes at 72 °C. Products were then resolved on polyacrylamide gels (10%) and stained with Gel Star (Biowhittaker, Rockland, MD, USA). Analysis of the intensity of band was realized using Quantity One software (Biorad, Hercules, CA, USA). To normalize mRNA levels in different samples, the value of the band corresponding to each mRNA level was divided by the intensity of the corresponding 28S rRNA band.
Semi-quantitative RT-PCR
In order to verify the specificity of amplification, PCR products were digested with appropriate restriction enzymes.
Western Blotting
Total protein extracts ( 
Statistical analysis
Results were expressed as mean ± SEM. Statistical test was assessed on experimental groups using Mann-Whitney test. Correlations were sought by calculating Spearman's coefficient of correlation. These tests were performed using GraphPad InStat software (http://www.graphpad.com/instat). Graphs were obtained using GrahPad Prism software (http://www.graphpad.com/prism). P values < 0.05 were considered as significant. Each experiment has been performed in duplicate. Two independent experiments have been performed for every experimental condition. Table : Cell counts in bronchoalveolar lavages in anti-ADAM-8-treated mice (1) and in ADAM-8 deficient mice (2) .
